D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 63 Citations 15,630 176 World Ranking 1505 National Ranking 130

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Gene
  • Internal medicine

The scientist’s investigation covers issues in Antibody, Virology, Epitope, Severe acute respiratory syndrome coronavirus 2 and Internal medicine. His work on Neutralization and Monoclonal antibody is typically connected to Antibody Classes as part of general Antibody study, connecting several disciplines of science. His Monoclonal antibody research includes themes of Lipid bilayer fusion, Peptide sequence, Cell biology, Allosteric regulation and Viral protein.

His work carried out in the field of Virology brings together such families of science as Early phase and Age and sex. The study incorporates disciplines such as Vaccine efficacy and Vaccination in addition to Internal medicine. His study with Ebola virus involves better knowledge in Immunology.

His most cited work include:

  • Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). (506 citations)
  • Genomic and epidemiological monitoring of yellow fever virus transmission potential (159 citations)
  • Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. (147 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Virology, Virus, Antibody, Ebola virus and Severe acute respiratory syndrome coronavirus 2. His Virology research incorporates elements of RNA and Immune system, Immunity. His research integrates issues of Transmission, Genome and Binding site in his study of Virus.

His research investigates the connection with Antibody and areas like Vaccination which intersect with concerns in Ebola vaccine. His Zaire ebolavirus study in the realm of Ebola virus connects with subjects such as Sierra leone. Miles W. Carroll conducts interdisciplinary study in the fields of Epitope and Coronavirus through his works.

He most often published in these fields:

  • Virology (77.42%)
  • Virus (48.39%)
  • Antibody (45.16%)

What were the highlights of his more recent work (between 2020-2021)?

  • Virology (77.42%)
  • Virus (48.39%)
  • Antibody (45.16%)

In recent papers he was focusing on the following fields of study:

His main research concerns Virology, Virus, Antibody, Severe acute respiratory syndrome coronavirus 2 and Immune system. His Virology study integrates concerns from other disciplines, such as RNA and Respiratory tract. His studies deal with areas such as Viral evolution, Sequence analysis and Genetic diversity as well as Virus.

His Antibody study frequently draws connections between adjacent fields such as Vaccination. Miles W. Carroll works mostly in the field of Immune system, limiting it down to concerns involving Ebola virus and, occasionally, Nucleoprotein and Virus classification. His studies in Neutralization integrate themes in fields like Anticoagulant, Receptor, IC50 and Heparin.

Between 2020 and 2021, his most popular works were:

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. (90 citations)
  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. (85 citations)
  • Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. (34 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Gene
  • Antibody

Miles W. Carroll mostly deals with Antibody, Virology, Neutralization, Monoclonal antibody and Virus. His work in the fields of Neutralizing antibody and Immunogenicity overlaps with other areas such as Coronavirus. Miles W. Carroll connects Virology with Severe acute respiratory syndrome coronavirus 2 in his research.

His Neutralization study incorporates themes from Vero cell, In vitro and Receptor. His Virus research integrates issues from RNA, Lung, Dose–response relationship and Nasal administration. He has included themes like Transmission, Booster dose and Viral replication in his Vaccination study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Real-time, portable genome sequencing for Ebola surveillance

Joshua Quick;Nicholas J. Loman;Sophie Duraffour;Jared T. Simpson;Jared T. Simpson.
Nature (2016)

939 Citations

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Ana Maria Henao-Restrepo;Anton Camacho;Ira M. Longini;Conall H. Watson.
The Lancet (2017)

773 Citations

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

Ana Maria Henao-Restrepo;Ira M Longini;Matthias Egger;Matthias Egger;Natalie E Dean.
The Lancet (2015)

741 Citations

GP100/PMEL 17 IS A MURINE TUMOR REJECTION ANTIGEN : INDUCTION OF SELF -REACTIVE, TUMORICIDAL T CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND

Willem W. Overwijk;Allan Tsung;Kari R. Irvine;Maria R. Parkhurst.
Journal of Experimental Medicine (1998)

546 Citations

Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line

Miles W Carroll;Bernard Moss.
Virology (1997)

507 Citations

Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes

Willem W. Overwijk;David S. Lee;Deborah R. Surman;Kari R. Irvine.
Proceedings of the National Academy of Sciences of the United States of America (1999)

506 Citations

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

V M Hirsch;T R Fuerst;G Sutter;M W Carroll.
Journal of Virology (1996)

472 Citations

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

Joshua Quick;Nathan D Grubaugh;Steven T Pullan;Ingra M Claro.
Nature Protocols (2017)

470 Citations

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

D Zhou;W Dejnirattisai;P Supasa;C Liu.
Cell (2021)

425 Citations

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing.
PLOS Medicine (2016)

412 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Miles W. Carroll

Bernard Moss

Bernard Moss

National Institutes of Health

Publications: 132

Nuno Rodrigues Faria

Nuno Rodrigues Faria

Imperial College London

Publications: 87

Nicholas P. Restifo

Nicholas P. Restifo

National Institutes of Health

Publications: 75

Oliver G. Pybus

Oliver G. Pybus

University of Oxford

Publications: 74

David C. Montefiori

David C. Montefiori

Duke University

Publications: 72

Kristian G. Andersen

Kristian G. Andersen

Scripps Research Institute

Publications: 63

Sarah C. Gilbert

Sarah C. Gilbert

University of Oxford

Publications: 56

Andrew Rambaut

Andrew Rambaut

University of Edinburgh

Publications: 56

Gerd Sutter

Gerd Sutter

Ludwig-Maximilians-Universität München

Publications: 54

Heinz Feldmann

Heinz Feldmann

National Institutes of Health

Publications: 46

Julian A. Hiscox

Julian A. Hiscox

University of Liverpool

Publications: 44

Teresa Lambe

Teresa Lambe

University of Oxford

Publications: 44

Norman L. Letvin

Norman L. Letvin

Beth Israel Deaconess Medical Center

Publications: 44

Jesse D. Bloom

Jesse D. Bloom

Fred Hutchinson Cancer Research Center

Publications: 42

Dan H. Barouch

Dan H. Barouch

Beth Israel Deaconess Medical Center

Publications: 41

Linda S. Wyatt

Linda S. Wyatt

National Institutes of Health

Publications: 40

Trending Scientists

Vladimir Aparin

Vladimir Aparin

Qualcomm (United Kingdom)

Chak K. Chan

Chak K. Chan

City University of Hong Kong

Jorge R. Frade

Jorge R. Frade

University of Aveiro

Michael D. Amiridis

Michael D. Amiridis

University of Illinois at Chicago

Miguel Teixeira

Miguel Teixeira

Universidade Nova de Lisboa

Jianglong Yu

Jianglong Yu

Monash University

Michael J. McPherson

Michael J. McPherson

University of Leeds

Francis X. McCormack

Francis X. McCormack

University of Cincinnati

Steven J. Davis

Steven J. Davis

University of California, Irvine

Michael E. Jenkin

Michael E. Jenkin

University of Bristol

Tania H. Watts

Tania H. Watts

University of Toronto

Carol L. Krumhansl

Carol L. Krumhansl

Cornell University

Ralph L. Piedmont

Ralph L. Piedmont

Loyola University Maryland

Michael V. Johnston

Michael V. Johnston

Kennedy Krieger Institute

S. Mark Pancer

S. Mark Pancer

Wilfrid Laurier University

Mark Chaffin

Mark Chaffin

University of Oklahoma Health Sciences Center

Something went wrong. Please try again later.